+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Recent Advances across Healthcare Biomarkers

  • ID: 4308233
  • Report
  • February 2017
  • Region: Global
  • 15 pages
  • Frost & Sullivan
1 of 2
This edition of the Genetic Technology TOE depicts trends across healthcare biomarkers. Different biomarkers including blood-based proteomics and immuno-oncology biomarkers are profiled through recent innovations.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 2
Recent Advances across Healthcare Biomarkers
  • Blood-based Proteomics for Breast Cancer Detection
  • Regulatory Approval for Biomarker-based Cancer Immunotherapy
  • Combating Drug Resistance in Oncology
  • Blood-based Biomarker Assay for Fibromyalgia Detection
Biomarker Analysis and Industry Interactions
  • Biomarker Analysis
  • Industry Interactions
Note: Product cover images may vary from those shown
3 of 2